Chunghwa Chemical Synthesis & Biotech Co Ltd (1762) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.028x

Based on the latest financial reports, Chunghwa Chemical Synthesis & Biotech Co Ltd (1762) has a cash flow conversion efficiency ratio of 0.028x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$90.44 Million ≈ $2.85 Million USD) by net assets (NT$3.18 Billion ≈ $100.19 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 1762 net asset quality score to measure how much of total assets are equity-financed.

Chunghwa Chemical Synthesis & Biotech Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2025)

This chart illustrates how Chunghwa Chemical Synthesis & Biotech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 1762 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Chunghwa Chemical Synthesis & Biotech Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Chunghwa Chemical Synthesis & Biotech Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Lee Chi Enterprises Co Ltd TW:1517	-0.021x
Gopeng Bhd KLSE:2135	-0.469x
Advero Properties SOCIMI S.A. MC:YADV	0.008x
Samsung Pharm KO:001360	-0.013x
Noble Development Public Company Limited BK:NOBLE	0.045x
Guizhou Zhongyida Co Ltd SHG:900906	0.195x
Nanoform Finland Plc HE:NANOFH	-0.076x
Iljin Diamond KO:081000	-0.022x

Annual Cash Flow Conversion Efficiency for Chunghwa Chemical Synthesis & Biotech Co Ltd (2008–2025)

The table below shows the annual cash flow conversion efficiency of Chunghwa Chemical Synthesis & Biotech Co Ltd from 2008 to 2025. For the full company profile with market capitalisation and key ratios, see 1762 market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	NT$3.09 Billion ≈ $97.27 Million	NT$142.61 Million ≈ $4.49 Million	0.046x	-66.84%
2024-12-31	NT$3.36 Billion ≈ $105.76 Million	NT$467.65 Million ≈ $14.73 Million	0.139x	+702.20%
2023-12-31	NT$3.35 Billion ≈ $105.55 Million	NT$-77.50 Million ≈ $-2.44 Million	-0.023x	-110.07%
2022-12-31	NT$3.19 Billion ≈ $100.60 Million	NT$733.78 Million ≈ $23.12 Million	0.230x	+203.46%
2021-12-31	NT$2.89 Billion ≈ $91.19 Million	NT$219.18 Million ≈ $6.91 Million	0.076x	+36.88%
2020-12-31	NT$2.50 Billion ≈ $78.72 Million	NT$138.24 Million ≈ $4.36 Million	0.055x	-58.42%
2019-12-31	NT$2.02 Billion ≈ $63.49 Million	NT$268.13 Million ≈ $8.45 Million	0.133x	+12.49%
2018-12-31	NT$1.98 Billion ≈ $62.50 Million	NT$234.66 Million ≈ $7.39 Million	0.118x	+35.20%
2017-12-31	NT$1.82 Billion ≈ $57.38 Million	NT$159.34 Million ≈ $5.02 Million	0.087x	-40.70%
2016-12-31	NT$1.77 Billion ≈ $55.80 Million	NT$261.31 Million ≈ $8.23 Million	0.148x	+245.00%
2015-12-31	NT$1.86 Billion ≈ $58.72 Million	NT$79.70 Million ≈ $2.51 Million	0.043x	+199.40%
2014-12-31	NT$1.62 Billion ≈ $50.91 Million	NT$23.08 Million ≈ $727.18K	0.014x	-83.17%
2013-12-31	NT$1.71 Billion ≈ $53.91 Million	NT$145.24 Million ≈ $4.58 Million	0.085x	-47.02%
2012-12-31	NT$1.68 Billion ≈ $52.79 Million	NT$268.46 Million ≈ $8.46 Million	0.160x	+85.46%
2011-12-31	NT$1.68 Billion ≈ $52.82 Million	NT$144.84 Million ≈ $4.56 Million	0.086x	-47.25%
2010-12-31	NT$1.68 Billion ≈ $53.01 Million	NT$275.61 Million ≈ $8.68 Million	0.164x	-57.67%
2009-12-31	NT$1.19 Billion ≈ $37.63 Million	NT$462.07 Million ≈ $14.56 Million	0.387x	+329.84%
2008-12-31	NT$837.53 Million ≈ $26.39 Million	NT$75.39 Million ≈ $2.38 Million	0.090x	--

About Chunghwa Chemical Synthesis & Biotech Co Ltd

TW:1762 Taiwan Biotechnology

Market Cap

$79.00 Million

NT$2.51 Billion TWD

Market Cap Rank

#20016 Global

#1164 in Taiwan

Share Price

NT$32.60

Change (1 day)

+1.24%

52-Week Range

NT$24.30 - NT$42.30

All Time High

NT$102.50